Genomic Valley Biotech Limited (BOM:539206)

India · Delayed Price · Currency is INR

41.56

+1.97 (4.98%)

At close: Oct 27, 2026

Market Cap	126.95M +42.8%
Revenue (ttm)	2.16M -72.3%
Net Income	202.67K -92.0%
EPS	0.07 -91.8%
Shares Out	3.05M
PE Ratio	613.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,606
Open	41.56
Previous Close	39.59
Day's Range	41.56 - 41.56
52-Week Range	20.10 - 41.56
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Genomic Valley Biotech

Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter gourd, bottle gourd, brinjal, broccoli, cabbage, capsicum, carrot, cauliflower, cucumber, green chilies, onion, radish, ridge/sponge gourd, leafy vegetables, pumpkin, banana, guava, papaya, and strawberry; and commercial floriculture of flowers. It also undertakes contracts for its clients for erecting greenhouses... [Read more]

Industry Agricultural Production Crops

Founded 1994

Employees 3

Stock Exchange Bombay Stock Exchange

Ticker Symbol 539206

Full Company Profile

Financial Performance

In fiscal year 2026, Genomic Valley Biotech's revenue was 2.68 million, a decrease of -68.30% compared to the previous year's 8.44 million. Earnings were 303,041, a decrease of -91.49%.

Financial Statements